<div id="readability-page-1"><p>Quantinno Capital Management LP boosted its holdings in shares of  Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 3.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 38,694 shares of the semiconductor company's stock after purchasing an additional 1,234 shares during the period. Quantinno Capital Management LP's holdings in Synopsys were worth $18,781,000 at the end of the most recent quarter.</p><ul><li>Market Overreaction: 2 Stocks to Buy on the Way Down</li></ul><p>Several other institutional investors have also made changes to their positions in the company. Norges Bank bought a new stake in  Synopsys in the 4th quarter valued at $583,608,000.  Price T Rowe Associates Inc. MD lifted its position in  Synopsys by 21.5% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 5,902,696 shares of the semiconductor company's stock worth $2,864,933,000 after buying an additional 1,045,326 shares in the last quarter.  Capital Research Global Investors bought a new position in  Synopsys in the 4th quarter worth approximately $239,864,000.  Raymond James Financial Inc. bought a new stake in shares of  Synopsys during the fourth quarter worth $199,065,000.  Finally, Ameriprise Financial Inc. boosted its stake in shares of  Synopsys by 26.2% in the 4th quarter. Ameriprise Financial Inc. now owns 1,888,181 shares of the semiconductor company's stock valued at $916,441,000 after purchasing an additional 391,681 shares during the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors. </p><h2>Insider Buying and Selling at Synopsys</h2><p>In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $463.75, for a total value of $5,270,982.50. Following the sale, the chief executive officer now directly owns 70,922 shares in the company, valued at approximately $32,890,077.50. The trade was a 13.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. Also, insider Geus Aart De sold 15,705 shares of Synopsys stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the completion of the transaction, the insider now directly owns 116,671 shares in the company, valued at approximately $51,850,925.82. This trade represents a 11.86% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.62% of the stock is owned by corporate insiders. </p><h2>Synopsys Trading Up 2.0%</h2><ul><li>MarketBeat Week in Review – 12/9 - 12/13</li></ul><p>Shares of NASDAQ:SNPS opened at $515.71 on Wednesday. The company has a market cap of $79.74 billion, a PE ratio of 35.52, a P/E/G ratio of 3.23 and a beta of 1.16. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $624.80. The company's 50 day moving average is $439.73 and its two-hundred day moving average is $489.24. </p><h2>Wall Street Analysts Forecast Growth</h2><p>Several analysts recently commented on the company. Mizuho dropped their price objective on Synopsys from $650.00 to $600.00 and set an &#34;outperform&#34; rating on the stock in a research note on Tuesday, April 15th. Wells Fargo &amp; Company dropped their target price on Synopsys from $540.00 to $520.00 and set an &#34;equal weight&#34; rating for the company in a report on Thursday, February 27th. Piper Sandler lowered their target price on Synopsys from $655.00 to $653.00 and set an &#34;overweight&#34; rating for the company in a report on Thursday, February 27th. Rosenblatt Securities  reissued a &#34;buy&#34; rating and issued a $660.00 price objective on shares of Synopsys in a research note on Tuesday, February 25th. Finally, Bank of America cut their price objective on shares of Synopsys from $630.00 to $560.00 and set a &#34;buy&#34; rating on the stock in a report on Wednesday, April 16th. One analyst  has rated the stock with a hold rating and twelve have issued  a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $613.43.</p><ul><li>Semiconductor Giant Synopsys Slides 14% — Time to Take Notice</li></ul><p><b>View Our Latest Analysis on SNPS</b></p><h2>About Synopsys</h2> (Free Report)<p>Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Synopsys</li><li>3 Monster Growth Stocks to Buy Now</li><li>Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore</li><li>Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?</li><li>AppLovin Surges on Earnings: What's Next for This Tech Standout?</li><li>Stock Market Holidays 2022-2025 - Here’s When the NYSE and NASDAQ Will be Closed</li><li>U.S. Regulators Target CrowdStrike: Is It a Signal or Noise? </li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U05QUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U05QUw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Synopsys Right Now?</h2><p>Before you consider Synopsys, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.</p><p>While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

SNPS

<p>Quantinno Capital Management LP increased its stake in Synopsys, Inc. (NASDAQ:SNPS) by 3.3% in Q4, owning 38,694 shares valued at $18.78 million. Other institutional investors also adjusted their positions, with Norges Bank acquiring a stake worth $583.6 million. CEO Sassine Ghazi sold 11,366 shares, reducing his ownership by 13.81%. Synopsys shares opened at $515.71, with a market cap of $79.74 billion. Analysts have mixed ratings, with a consensus target price of $613.43 and several buy ratings issued.</p>

Synopsys, Inc. (NASDAQ:SNPS) Shares Purchased by Quantinno Capital Management LP